Literature DB >> 11344525

Deproteinization of serum: another best approach to eliminate all forms of bilirubin interference on serum creatinine by the kinetic Jaffe reaction.

P H Lolekha1, S Jaruthunyaluck, P Srisawasdi.   

Abstract

The negative interference of conjugated, unconjugated, and delta bilirubin on patient serum creatinine determined by the kinetic Jaffe reaction is the unresolved problem. We compared bilirubin interference on thirty patients' serum creatinine obtained from four analyzers, with and without deprotenization before the Jaffe reaction, to the Vitros dry enzymatic method. We found significant negative interference from bilirubin on serum creatinine in all samples directly applied to four wet chemical methods, except the one incorporated with serum blank rate. The negative interferences linearly related to bilirubin concentration. However, bilirubin did not interfere on serum creatinine obtained from all wet chemical methods incorporated with deproteinization process before the reaction. We conclude that deproteinized serum before the reaction is the best approach to eliminate all forms of bilirubin interference on serum creatinine determined by the kinetic Jaffe reaction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344525      PMCID: PMC6807905          DOI: 10.1002/jcla.1013

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  12 in total

1.  Correlation of neonatal serum total bilirubin concentrations and developmental status at age eight months. A preliminary report from the collaborative project.

Authors:  T R Boggs; J B Hardy; T M Frazier
Journal:  J Pediatr       Date:  1967-10       Impact factor: 4.406

2.  Development of an automated kinetic Jaffé method designed to minimise bilirubin interference in plasma creatinine assays.

Authors:  M L Knapp; P D Mayne
Journal:  Clin Chim Acta       Date:  1987-09-30       Impact factor: 3.786

3.  Determination of serum creatinine by a direct colorimetric method.

Authors:  D Heinegård; G Tiderström
Journal:  Clin Chim Acta       Date:  1973-02-12       Impact factor: 3.786

4.  Creatinine assay in the presence of protein.

Authors:  J G Cook
Journal:  Clin Chim Acta       Date:  1971-05       Impact factor: 3.786

Review 5.  Analytical reviews in clinical biochemistry: the estimation of creatinine.

Authors:  K Spencer
Journal:  Ann Clin Biochem       Date:  1986-01       Impact factor: 2.057

6.  Automated reaction-rate method for determination of serum creatinine with the CentrifiChem.

Authors:  D L Fabiny; G Ertingshausen
Journal:  Clin Chem       Date:  1971-08       Impact factor: 8.327

7.  Elimination of bilirubin interference in creatinine assays by routine techniques: comparisons with a high performance liquid chromatography method.

Authors:  S Boot; N LaRoche; E F Legg
Journal:  Ann Clin Biochem       Date:  1994-05       Impact factor: 2.057

8.  Evaluation of serum creatinine measurement by the direct acidification method for errors contributed by non-creatinine chromogens.

Authors:  P H Lolekha; R Taksinamanee
Journal:  Clin Chim Acta       Date:  1980-10-23       Impact factor: 3.786

9.  Reaction of picrate with creatinine and cepha antibiotics.

Authors:  M H Kroll; C Hagengruber; R J Elin
Journal:  Clin Chem       Date:  1984-10       Impact factor: 8.327

10.  Comparison of techniques for minimizing interference of bilirubin on serum creatinine determined by the kinetic Jaffé reaction.

Authors:  P H Lolekha; N Sritong
Journal:  J Clin Lab Anal       Date:  1994       Impact factor: 2.352

View more
  14 in total

1.  Comparison of methods, storage conditions, and time to analysis of serum and urine creatinine measured from microsamples by liquid chromatography mass spectrometery (LC/MS) vs. Jaffe.

Authors:  David J Askenazi; John F Moore; Naomi Fineberg; Rajesh Koralkar; Stephanie Clevenger; Jon Daniel Sharer
Journal:  J Clin Lab Anal       Date:  2014-03-20       Impact factor: 2.352

2.  Modification of Jaffe's kinetic method decreases bilirubin interference: A preliminary report.

Authors:  R Vaishya; Sarika Arora; B Singh; V Mallika
Journal:  Indian J Clin Biochem       Date:  2010-02-10

3.  Exogenous interferences with Jaffe creatinine assays: addition of sodium dodecyl sulfate to reagent eliminates bilirubin and total protein interference with Jaffe methods.

Authors:  P Srisawasdi; U Chaichanajarernkul; N Teerakanjana; S Vanavanan; M H Kroll
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Creatinine estimation and interference.

Authors:  Kirtimaan Syal; Dibyajyoti Banerjee; Anand Srinivasan
Journal:  Indian J Clin Biochem       Date:  2013-01-26

5.  AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure.

Authors:  Rakhi Maiwall; Guresh Kumar; Ankit Bharadwaj; Kapil Jamwal; Ajeet Singh Bhadoria; Priyanka Jain; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-10-05       Impact factor: 6.047

Review 6.  Evaluation and management of critically ill children with acute kidney injury.

Authors:  David Askenazi
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

7.  Acute kidney injury in premature newborns-definition, etiology, and outcome.

Authors:  Vesna Stojanović; Nenad Barišić; Tanja Radovanović; Milena Bjelica; Borko Milanović; Aleksandra Doronjski
Journal:  Pediatr Nephrol       Date:  2017-05-29       Impact factor: 3.714

8.  Bilirubin Interference in Serum Creatinine Estimation by Jaffe's kinetic Method and Its Rectification in Three Different Kits.

Authors:  Prabhat Kumar Nigam
Journal:  Indian J Clin Biochem       Date:  2016-01-19

Review 9.  Acute kidney injury in critically ill newborns: what do we know? What do we need to learn?

Authors:  David J Askenazi; Namasivayam Ambalavanan; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

10.  Limitations of early serum creatinine variations for the assessment of kidney injury in neonates and infants with cardiac surgery.

Authors:  Mirela Bojan; Vanessa Lopez-Lopez; Philippe Pouard; Bruno Falissard; Didier Journois
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.